The question was valuation in the next 3-9 months, so with that in mind, I don't think mnta will have refiled in that time frame. So that rules out a couple of scenarios.
I would look at the bull case as progress on 118, copaxone anda filing would be very nice and just clarity on lovenox, will they refile and when?
Market Data 
Markets 
AI
